Latest Prescription Drugs news
U.S. Buys 600,000 Doses of New COVID-19 Treatment Still Awaiting FDA Approval
posted February 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Panel Rejects Lilly Cancer Drug Tested Only in China
posted February 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves New Antibody Drug to Fight Omicron Variant
posted February 11th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adding Tirzepatide to Insulin Glargine Ups Glycemic Control in T2DM
posted February 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers .jpg)
Pregnancy Complications Linked to Subsequent Risk for Cardiometabolic-Renal Conditions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults Monthly Specialist Briefings
Stay Connected
